Testing effectiveness (Phase 2)Ended earlyNCT03301597What this trial is testingNLA101 in Adults Receiving High Dose Chemotherapy for AMLWho this might be right forLeukemia, Myeloid, Acute Nohla Therapeutics, Inc. 146
Testing effectiveness (Phase 2)Looking for participantsNCT05194397What this trial is testingExercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT SurvivorsWho this might be right forLymphoblastic LeukemiaCancer SurvivorsAplastic Anemia+2 more Children's Hospital of Philadelphia 80
Not applicableLooking for participantsNCT06535113What this trial is testingDecoding the Inflammasome Influence on Treatment Response in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Ciceri Fabio 80
Testing effectiveness (Phase 2)Ended earlyNCT01034410What this trial is testingAS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Antisoma Research 90
Testing effectiveness (Phase 2)Ended earlyNCT06268574What this trial is testingSafety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AMLWho this might be right forAcute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome Ryvu Therapeutics SA 62
Testing effectiveness (Phase 2)Looking for participantsNCT04068597What this trial is testingStudy to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesWho this might be right forHaematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more CellCentric Ltd. 250
Not applicableUnknownNCT01966497What this trial is testingObservational Study of Patients Older Than 60 Years With Acute Myeloblastic LeukemiaWho this might be right forAcute Myeloblastic LeukemiaAged Higher Than 60 Years Old Assistance Publique - Hôpitaux de Paris 1,000
Not applicableStudy completedNCT06211153What this trial is testingReal-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)Who this might be right forChronic Myeloid Leukemia With T315I Mutation Novartis Pharmaceuticals 31
Not applicableNo Longer AvailableNCT04678466What this trial is testingFlotetuzumab Expanded Access ProgramWho this might be right forAcute Myeloid LeukemiaAMLAML, Adult Recurrent MacroGenics
Early research (Phase 1)Looking for participantsNCT06634394What this trial is testingAPVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AMLWho this might be right forAcute Myeloid Leukemia (AML) Aptevo Therapeutics 39
Testing effectiveness (Phase 2)Looking for participantsNCT03589729What this trial is testingDexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersWho this might be right forAcute Myeloid LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveBlasts 10 Percent or More of Bone Marrow Nucleated Cells+4 more M.D. Anderson Cancer Center 100
Large-scale testing (Phase 3)Study completedNCT02472145What this trial is testingAn Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyWho this might be right forLeukemia, Myeloid, Acute Janssen Research & Development, LLC 326
Large-scale testing (Phase 3)Study completedNCT00148421What this trial is testingStudy for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.Who this might be right forAnemia Amgen
Not applicableStudy completedNCT00281814What this trial is testingCaregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 36
Early research (Phase 1)WithdrawnNCT03807063What this trial is testingRivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWho this might be right forAcute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT04175587What this trial is testingRandomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APLWho this might be right forAcute Promyelocytic Leukaemia Peking University People's Hospital 109
Early research (Phase 1)UnknownNCT05426798What this trial is testingClinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic SyndromesWho this might be right forRecurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 73
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT06088888What this trial is testingTGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous LeukemiaWho this might be right forChronic Myelogenous Leukemia Shenzhen TargetRx Co., Ltd. 90
Early research (Phase 1)WithdrawnNCT05519527What this trial is testingSTI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisWho this might be right forRefractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML) M.D. Anderson Cancer Center